Barclays Maintains Underweight on FMC, Lowers Price Target to $11

Benzinga Newsdesk www.benzinga.com Negative 79.2%

Neg 79.2% Neu 0% Pos 0%

Barclays analyst Benjamin Theurer maintains FMC (NYSE:FMC) with a Underweight and lowers the price target from $13 to $11.